Waning immunity of the BNT162b2 vaccine: A nationwide study from Israel

Yair Goldberg, Micha Mandel, Yinon M. Bar-On, Omri Bodenheimer, Laurence Freedman, Eric J. Haas, Ron Milo, Sharon Alroy-Preis, Nachman Ash, Amit Huppert
doi: https://doi.org/10.1101/2021.08.24.21262423

Article Information

doi 
https://doi.org/10.1101/2021.08.24.21262423
History 
  • August 30, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Yair GoldbergϮ,1,*,
  2. Micha MandelϮ,2,
  3. Yinon M. Bar-On3,
  4. Omri Bodenheimer4,
  5. Laurence Freedman5,
  6. Eric J. Haas4,7,
  7. Ron Milo3,
  8. Sharon Alroy-Preis&,4,
  9. Nachman Ash&,4 and
  10. Amit Huppert&,5,6
  1. 1Technion - Israel Institute of Technology, Israel
  2. 2The Hebrew University of Jerusalem, Israel
  3. 3Weizmann Institute of Science, Israel
  4. 4Israel Ministry of Health, Israel
  5. 5The Gertner Institute for Epidemiology & Health Policy Research, Sheba Medical Center, Israel
  6. 6Tel Aviv University, Israel
  7. 7Ben Gurion University, Beersheva, Israel
  1. ↵*corresponding author email: yairgo{at}technion.ac.il

  1. ↵Ϯ Contributed equally.

  2. ↵& Contributed equally.

Back to top
Posted August 30, 2021.
Download PDF
Data/Code
Email
Waning immunity of the BNT162b2 vaccine: A nationwide study from Israel
Yair Goldberg, Micha Mandel, Yinon M. Bar-On, Omri Bodenheimer, Laurence Freedman, Eric J. Haas, Ron Milo, Sharon Alroy-Preis, Nachman Ash, Amit Huppert
medRxiv 2021.08.24.21262423; doi: https://doi.org/10.1101/2021.08.24.21262423
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area